Accepted 21 April 2014 Published online 11 July 2014 in Wiley Online Library (wileyonlinelibrary.com). DOI /hed.23715
|
|
- Claude Chandler
- 6 years ago
- Views:
Transcription
1 ORIGINAL ARTICLE Acute and late side effects to salivary glands and oral mucosa after head and neck radiotherapy in children and adolescents. Results of the Registry for the evaluation of side effects after radiotherapy in childhood and adolescence Tobias B olling, MD, 1,2* Julia Weege, 1 Hans Theodor Eich, MD, 1 Beate Timmermann, MD, 3,4 Frank-Michal Meyer, MD, 5 Christian R ube, MD, 6 Rolf-Dieter Kortmann, MD, 7 Karin Fischedick, MD, 8 Claus R odel, MD, 9 Raphael Koch, 10 Normann Willich, MD 1 1 Department of Radiotherapy, University Hospital of M unster, M unster, Germany, 2 Center for Radiotherapy Rheine/Osnabr uck, Osnabr uck, Germany, 3 Western German Proton Therapy Center, University Hospital of Essen, Essen, Germany, 4 Center for Proton Radiation Therapy, Paul Scherrer Institute, Villigen, Switzerland, 5 Department of Radiotherapy, Clinic Augsburg, Augsburg, Germany, 6 Department of Radiotherapy, University Hospital of Homburg/Saar, Homburg/Saar, Germany, 7 Department of Radiotherapy, University Hospital of Leipzig, Leipzig, Germany, 8 Department of Radiotherapy, University Hospital of Aachen, Aachen, Germany, 9 Department of Radiotherapy, University Hospital of Frankfurt, Frankfurt, Germany, 10 Institute of Biostatistics and Clinical Research (IBKF), University of M unster, M unster, Germany. Accepted 21 April 2014 Published online 11 July 2014 in Wiley Online Library (wileyonlinelibrary.com). DOI /hed ABSTRACT: Background. The registry for the evaluation of side effects after radiotherapy in childhood and adolescence (RiSK) was established to prospectively characterize radiation-associated side effects. The purpose of this analysis was to characterize side effects after radiotherapy to the head and neck in children and adolescents. Methods. Radiation doses have been collected across Germany since Acute and late side effects were characterized. Results. Until January 2010, 133 patients (median age, 12.7 years) were recruited who had received radiotherapy to the salivary glands. Toxicity evaluation was available for 114 patients (median follow-up, 2.9 years). Acute and late toxicity significantly depended on the maximum radiation dose to the salivary glands. An increase of the mean value of maximum dose of 1 Gray (Gy) to the submandibular glands resulted in an odds ratio of 1.04 (range, ; p 5.039) for acute toxicities of the salivary glands and 1.08 (range, ; p 5.001) for acute mucosal toxicities. Conclusion. These data can be used for an individual risk assessment in pediatric head and neck radiotherapy. VC 2014 Wiley Periodicals, Inc. Head Neck 37: , 2015 KEY WORDS: radiation, head and neck, salivary gland, childhood, adolescence INTRODUCTION The characterization of the effects of cancer therapy in children and adolescents has been of increasing interest because of the high cure rates of cancer using modern multimodal therapy. 1,2 Retrospective analyses on radiation-associated side effects have mainly been performed with unclear estimates of the radiation characteristics because of a lack of detailed organ dose documentation. Several study groups in a variety of countries have developed strategies to characterize different aspects of these late effects. The largest examination was performed in the United States using the Childhood Cancer Survivor Study (CCSS). The CCSS was established to retrospectively characterize the health status of 5-year survivors of childhood cancer. 3 In these studies, more than 12,000 patients were evaluated by questionnaires regarding their health status in comparison with their siblings. 2 Regarding radiation-associated late sequelae, studies within the CCSS setting cannot be based on detailed *Corresponding author: T. B olling, Center for Radiotherapy Rheine/Osnabr uck, Am Finkenh ugel 5, Osnabr uck, Germany. pd.dr.boelling@strahlenbehandlung.de Contract grant sponsor: The Deutsche Kinderkrebsstiftung, Bonn, Germany. information about radiation doses at organs at risk. The CCSS database includes radiotherapy treatment parameters, such as the first and last dates of treatment, the body region treated, the beam energy, the treatment field size, configuration and laterality, and the total treatment dose. 1 The acquisition of further data with retrospective reconstruction of doses at the organs at risk is described to be possible for special questions in subgroups of patients. 1 Although the approach of the CCSS has led to interesting analyses of many late sequelae, this approach may not be sufficient to answer open questions regarding the dosevolume-effect relationships of late effects in pediatric oncology patients treated with radiation. In Germany, the registry for the evaluation of side effects after radiation in childhood and adolescence (RiSK) has been established by the German Group of Pediatric Radiation Oncology, a working group of the German Society of Radiation Oncology, and the German Society of Pediatric Oncology and Hematology (GPOH). The purpose of this prospective multicenter registry was to evaluate radiation dose-effect relationships in organs and parts of organs after radiotherapy, including combined modality treatments with surgery and/or chemotherapy. The feasibility of RiSK has already been shown and initial results have been published. 4 8 The intention of the present analysis was to characterize salivary gland function and mucosa HEAD & NECK DOI /HED AUGUST
2 BÖLLING ET AL. TABLE 1. Overview about number of patients (percentage) with documented acute side effects, maximal late side effects and late side effects at the last documentation. No. of patients (%) by toxicity grade Grade 0 Grade 1 Grade 2 Grade 3 Grade 4 Mucosa Acute toxicity 52 (43) 30 (25) 25 (21) 11 (9) 2 (2) Maximal late toxicity 96 (90) 8 (7) 3 (3) 0 (0) 0 (0) Late toxicity last documentation 99 (93) 6 (5) 2 (2) 0 (0) 0 (0) Salivary glands Acute toxicity 84 (74) 22 (19) 5 (4) 3 (3) 0 (0) Maximal late toxicity 95 (90) 7 (7) 3 (3) 0 (0) 0 (0) Late toxicity last documentation 100 (95) 3 (3) 2 (2) 0 (0) 0 (0) toxicity in children and adolescents who had been irradiated to the head and neck region. PATIENTS AND METHODS The structure, study protocol, and original documentation forms for RiSK have already been published. 9 Briefly, documentation has been performed prospectively with detailed, standardized forms, which included radiation parameters, such as the irradiation technique used, the duration of the radiation, and the irradiation doses to all organs. The maximal radiation doses (as given in the treatment planning system) to the salivary glands (parotid and submandibular glands) were recorded based on the individual treatment planning using 3D treatment plans. However, complete dose volume histograms (DVHs) were not available. Doses to the salivary glands were recorded if at least 1 salivary gland was partly within the radiation fields. In case of intensity-modulated radiotherapy (IMRT), all patients with head and neck radiotherapy have been documented. Whether the entire salivary gland was included in the field of radiation was also recorded. During follow-up examinations, salivary gland function and mucosal status were evaluated according to Radiation Therapy Oncology Group/European Organization for Research and Treatment of Cancer criteria. Toxicity follow-up examinations were scheduled to be performed within 8 weeks after the end of radiotherapy for acute toxicities and at least once a year for late toxicities. The children and adolescents included in this analysis received radiotherapy in one of the therapy-optimizing study trials of the GPOH. The radiotherapy documentation was performed through local radiotherapists and the documentation forms were reviewed and collected in the study center. The study began in only a few centers in 2001, but, starting in 2004, documentation was performed all over Germany. Documentation and all statistical analyses were performed using the commercially available programs SPSS 20.0 (IBM, Armonk, NY) and SAS (SAS Institute, Cary, NC). In addition to descriptive analyses, the chi-square test, the exact Fisher test, and the Mann Whitney U test were used for univariate analyses. Box plot analyses helped to visualize data distribution. Multivariate analyses were performed using the binary logistic regression analysis. Inferential statistics were intended to be exploratory (hypothesis generating), not confirmatory, and were interpreted accordingly. The comparison-wise type I error rate was controlled instead of the experimentwise error rate. The local significance level was set to No adjustment for multiple testing was performed; therefore, an overall significance level was not determined and could not be calculated. RESULTS From June 2001 until January 2010, 1175 patients from 62 centers had been entered into the RiSK database. Of these, radiotherapy covered the salivary glands in 133 patients. The median age at radiotherapy was 12.7 years (range, years; 51.9% male). Most patients were diagnosed with Hodgkin lymphoma (n 5 66) and rhabdomyosarcomas (n 5 40), others had nasopharyngeal carcinomas (n 5 7), different sarcomas (n 5 5), and a variety of rare diseases (n 5 15). Radiotherapy was mainly performed using photon therapy (n 5 105); proton therapy (n 5 27), electrons (n 5 3), or cobalt therapy (n 5 2) were also used. Some patients (n 5 4) were treated using a combination of different techniques. The median prescribed target volume dose was 36 Gray (Gy; range, Gy), single doses showed a range from 1.0 (twice daily) to 2.5 Gy (once a day). The maximum doses to the parotid and submandibular glands were in median 20 Gy (range, 0 80 Gy and 0 67 Gy). For further analyses, the mean dose of the maximum doses for the right and left salivary glands were calculated. Almost all patients (94.7%) were given chemotherapy before radiotherapy; the therapy was performed within one of the therapy optimizing trials of the GPOH. One third of all patients (n 5 44) received simultaneous chemotherapy and radiation. Multiple different chemotherapy schedules have been used including vincristine, adriamycin, etoposide, cyclophosphamide, ifosfamide, procarbacine, and a variety of further agents, according to the corresponding treatment protocols. Follow-up information regarding salivary gland function and mucosa toxicity was available for 114 patients (85.7%) with a median follow-up time of 2.9 years (range, years). A detailed overview about acute, maximal toxicity, and toxicity at the last documentation is given in Table 1. The maximal late toxicity for mucosa and salivary glands was documented in a median of 1.16 years after radiotherapy (range, years). Information regarding radiation doses at the mucosa was not available. Calculations were performed with documented 1138 HEAD & NECK DOI /HED AUGUST 2015
3 SIDE EFFECTS AFTER HEAD AND NECK RADIOTHERAPY IN CHILDREN FIGURE 1. Box plot analyses of acute and maximal late toxicity to the salivary glands and mucosa dependent on the mean values of maximum doses to the parotid and submandibular glands. All differences are statistically significant: comparison of acute toxicity to salivary glands and mucosa with doses to submandibular and parotid gland, p <.001; maximal late effects to salivary glands, p 5.05 (parotid gland), p (submandibular gland); and maximal late effects to mucosa, p (parotid gland), p (submandibular gland). [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.] radiation doses at the salivary glands (for estimation) instead. Figure 1 shows box plot analyses regarding the distribution of mean values (of right and left parotid gland) of maximum doses to the salivary glands in view of acute toxicity, maximal late effects, and late toxicity at last documentation. Statistically significant differences can be observed with a clear dose effect relationship. In general, side effects were seen in patients who had received radiation doses to the salivary glands exceeding 20 Gy. In univariate analyses, age at radiotherapy, sex, and chemotherapy before or after radiation did not have any impact on toxicity. However, concurrent chemotherapy during radiation showed significant differences. For patients with and without concurrent chemotherapy, the odds ratios (ORs) were 3.64 (95% confidence interval [CI] ) and 8.28 (95% CI, ) in view of acute toxicity to salivary glands (p 5.005) and mucosa (p <.001). For late toxicities, a significant difference (p 5.026) could be observed for salivary gland function (OR, 5.15; 95% CI, ), whereas there was no significant difference for mucosa (p 5.065). A further differentiation of chemotherapy subgroups was not feasible because of the broad variety of chemotherapy schedules. The different diagnoses showed a significant difference in toxicities (p <.001) as they also represent the different radiation doses. Patients diagnosed with sarcomas were treated with higher radiation doses (resulting in higher radiation doses to the salivary glands) than patients diagnosed with Hodgkin lymphoma. A similar effect could be observed for the analysis of radiation techniques. In a univariate analysis comparing patients treated with protons to those treated with photons (without consideration of different radiation doses), children treated with protons had higher rates of mucosal toxicity. This effect also reflects the different radiation doses as children and adolescents treated with protons predominantly had been diagnosed with sarcomas. All patients diagnosed with Hodgkin lymphoma (who were treated with lower radiation doses) were treated with photons. Acute toxicity to the salivary glands and the late toxicities showed no significant difference between photon and proton therapy in univariate analyses. Multivariate analyses using a binary logistic regression model could be performed for acute toxicities. An increase of the mean value of a maximum dose of 1 Gy to the submandibular glands resulted in an OR of 1.04 (95% CI, ; p 5.039) for acute toxicities of the salivary glands and an OR of 1.08 (95% CI, ; p 5.001) for acute mucosal toxicities. No significant differences could be seen for parotid glands. Patients with concurrent chemotherapy during radiation had an OR of HEAD & NECK DOI /HED AUGUST
4 BÖLLING ET AL (p <.001) for acute mucosal side effects. The radiation techniques (photons vs protons) also showed significant differences. Patients treated with protons had an OR of 0.12 (95% CI, ; p 5.002) in view of acute side effects to the salivary glands. For acute mucosal toxicity, no significant difference could be observed. The reason for this result is discussed in detail. Because of the patient numbers, a multivariate analysis could not be established for late toxicities. DISCUSSION Xerostomia and mucosal damage are well known phenomena in adult patients with head and neck cancer. Several reports describe incidences of radiation-induced damages for several techniques. In a comprehensive review, Deasy et al 10 describe that severe xerostomia could usually be avoided if at least 1 parotid gland was spared to ameandoseof<20 Gy or if both glands were spared to <25 Gy. Tuan et al 11 report a xerostomia rate of 46% after a median follow-up time of 7.2 years in 796 patients conventionally irradiated for nasopharyngeal carcinoma. Different models have been established to try to predict the xerostomia risk in dependence on radiation dose and volume with consideration of innovative radiation techniques like IMRT. Beetz et al 12 investigated the ability of predictive models for patient-rated xerostomia after primary (chemo)radiation in patients with head and neck cancer treated with 3D-conformal radiotherapy to predict outcome in patients treated with IMRT. The 3D-based models turned out to be less valid for patients treated with IMRT. The authors concluded that models developed in a population treated with a specific technique cannot be generalized and extrapolated to a population treated with another technique without external validation. Buettner et al 13 presented novel dose response models taking the spatial distribution of the radiation dose into account. The radiation dose to the submandibular gland and other clinical factors were considered. They used a variable-selection algorithm to select the best dose response model. Beneficial dosepattern analysis demonstrated the importance of minimizing the dose to the lateral and cranial component of the parotid gland in order to avoid xerostomia. In contrast to a broad variety of analyses regarding radiation-induced xerostomia in adults, little is known about this side effect in children and adolescents. In 2000, Paulino et al 14 published an analysis regarding the long-term effects in 17 children receiving radiotherapy for head and neck rhabdomyosarcoma. Late effects of treatment were seen in all patients and included facial growth retardation in 11 and dental abnormalities in 7 patients. However, data regarding salivary gland function was not presented. Meazza et al 15 published a series of 90 pediatric patients diagnosed with head and neck rhabdomyosarcoma. Late toxicity analyses could be performed in 36 patients. The most common side effects were facial growth retardation and dental abnormalities. Xerostomia occurred in 38% of all patients. Analyses regarding radiation dose effect relationships were not performed. Our results regarding salivary function and mucosal damage after radiotherapy to the head and neck region in children and adolescents are in concordance with published data regarding adult patients. Clear dose effect relationships could be shown and individual risk estimations are made available. A multivariate analysis revealed significant differences in acute toxicity in patients treated with photons and protons independently of the mean values of maximum doses to the salivary glands. We do not think that this reflects different biological mechanisms but results from different DVHs for the parotid gland because of the dose gradient in proton therapy (with better organ sparing using proton therapy). The most limiting factor of our analysis was the absence of DVH parameters of the salivary glands. In the beginning of the development of the study design in the late 1990s, DVHs were not standard in all treatment institutions. Therefore, a more detailed documentation has not been performed. The difference between acute toxicities in patients treated with protons and photons may be explained by different DVHs with the same mean values of maximum doses. Therefore, the evaluation of new treatment approaches in pediatric patients diagnosed with tumors in the head and neck region will be of major interest. CONCLUSION Radiation-associated acute and late side effects in view of salivary gland function and mucosal status in childhood and adolescence show a clear dose-effect relationship that is comparable to those in adults. An increase of the mean value of the maximum dose of 1 Gy to the submandibular glands resulted in an OR of 1.04 for acute toxicities of the salivary glands. Concurrent chemotherapy during radiation highly increases the risk for acute as well as late salivary gland and mucosa toxicity. Proton therapy may have the potential to reduce side effects. However, this has to be proven in further clinical studies. Acknowledgments The authors acknowledge the financial support of the Deutsche Kinderkrebsstiftung, Bonn, Germany. The authors thank all persons who performed documentation for this study. Sincere thanks are given to the documentation staff in the RiSK study trial center and the Center for Clinical Trials at the University Hospital M unster. REFERENCES 1. Leisenring WM, Mertens AC, Armstrong GT, et al. Pediatric cancer survivorship research: experience of the Childhood Cancer Survivor Study. J Clin Oncol 2009;27: Robison LL, Armstrong GT, Boice JD, et al. The Childhood Cancer Survivor Study: a national cancer institute-supported resource for outcome and intervention research. J Clin Oncol 2009;27: Hudson MM, Mulrooney DA, Bowers DC, et al. High-risk populations identified in Childhood Cancer Survivor Study Investigations: implications for risk-based surveillance. J Clin Oncol 2009;27: B olling T, Schuck A, R ube C, et al. Therapy-associated late effects after irradiation of malignant diseases in childhood and adolescence. Feasibility analyses of a prospective multicenter register study [in German]. Strahlenther Onkol 2006;182: Willich N, Ernst I, Pape H, et al. Evaluation of side effects after radiotherapy in childhood and adolescence: from retrospective case reports to a prospective, multicentric and transnational approach. Strahlenther Onkol 2009;185 Suppl 2: B olling T, Ernst I, Pape H, et al. Dose-volume analysis of radiation nephropathy in children: preliminary report of the RiSK Consortium. Int J Radiat Oncol Biol Phys 2011;80: B olling T, Geisenheiser A, Pape H, et al. Hypothyroidism after head-andneck radiotherapy in children and adolescents: preliminary results of the Registry for the Evaluation of Side Effects After Radiotherapy in Childhood and Adolescence (RiSK). Int J Radiat Oncol Biol Phys 2011;81: e787 e HEAD & NECK DOI /HED AUGUST 2015
5 SIDE EFFECTS AFTER HEAD AND NECK RADIOTHERAPY IN CHILDREN 8. Selo N, B olling T, Ernst I, et al. Acute toxicity profile of radiotherapy in 690 children and adolescents: RiSK data. Radiother Oncol 2010;97: B olling T, Schuck A, Pape H, et al. Study protocol of the German Registry for the detection of late sequelae after radiotherapy in childhood and adolescence (RiSK). Radiat Oncol 2008;3: Deasy JO, Moiseenko V, Marks L, Chao KSC, Nam J, Eisbruch A. Radiotherapy dose-volume effects on salivary gland function. Int J Radiat Oncol Biol Phys 2010;76(3 Suppl):S58 S Tuan JK, Ha TC, Ong WS, et al. Late toxicities after conventional radiation therapy alone for nasopharyngeal carcinoma. Radiother Oncol 2012;104: Beetz I, Schilstra C, van Luijk P, et al. External validation of three dimensional conformal radiotherapy based NTCP models for patient-rated xerostomia and sticky saliva among patients treated with intensity modulated radiotherapy. Radiother Oncol 2012;105: Buettner F, Miah AB, Gulliford SL, et al. Novel approaches to improve the therapeutic index of head and neck radiotherapy: an analysis of data from the PARSPORT randomised phase III trial. Radiother Oncol 2012;103: Paulino AC, Simon JH, Zhen W, Wen BC. Long-term effects in children treated with radiotherapy for head and neck rhabdomyosarcoma. Int J Radiat Oncol Biol Phys 2000;48: Meazza C, Ferrari A, Casanova M, et al. Evolving treatment strategies for parameningeal rhabdomyosarcoma: the experience of the Istituto Nazionale Tumori of Milan. Head Neck 2005;27: HEAD & NECK DOI /HED AUGUST
Pediatrics -Proton Beam Therapy in Children -
Pediatrics -Proton Beam Therapy in Children - Beate Timmermann, M.D. West German Proton Therapy Centre Essen Germany Preview Survival Toxicity Why protons? (theoretically) Experiences so far (clinically)
More informationSecond Neoplasms Working Group. CCSS Investigators Meeting June 2017
Second Neoplasms Working Group CCSS Investigators Meeting June 2017 Second Neoplasms Working Group Overview Ongoing review, adjudication and entry of reported neoplasms into data set Initial review of
More informationLong-term parotid gland function after radiotherapy
Parotid gland sparing radiotherapy, P.M. Braam Chapter 2 Long-term parotid gland function after radiotherapy Pètra M. Braam 1, Judith M. Roesink 1, Marinus A. Moerland 1, Cornelis P.J. Raaijmakers 1, Maria
More informationORIGINAL ARTICLE GAMMA KNIFE STEREOTACTIC RADIOSURGERY FOR SALIVARY GLAND NEOPLASMS WITH BASE OF SKULL INVASION FOLLOWING NEUTRON RADIOTHERAPY
ORIGINAL ARTICLE GAMMA KNIFE STEREOTACTIC RADIOSURGERY FOR SALIVARY GLAND NEOPLASMS WITH BASE OF SKULL INVASION FOLLOWING NEUTRON RADIOTHERAPY James G. Douglas, MD, MS, 1,2 Robert Goodkin, MD, 1,2 George
More informationLessons from treatment of pediatric sarcomas at difficult sites. Dr. Andrea Ferrari Pediatric Oncology Unit Istituto Nazionale Tumori, Milan, Italy
Lessons from treatment of pediatric sarcomas at difficult sites Dr. ndrea Ferrari Pediatric Oncology Unit stituto Nazionale Tumori, Milan, taly Disclosure slide have no potential conflicts of interest
More informationOsteoradionecrosis and Radiation Dose to the Mandible in Patients With Oropharyngeal Cancer
International Journal of Radiation Oncology biology physics www.redjournal.org Clinical Investigation: Head and Neck Cancer Osteoradionecrosis and Radiation Dose to the Mandible in Patients With Oropharyngeal
More information8/16/2011. (Blanco et al. IJROBP 2005) (In press, IJROBP)
Methodological issues and key results in the QUANTEC 2010 review of quantitative analysis of normal tissue effects in the clinic (The QUANTEC steering committee:) Soeren Bentzen, Sandy Constine, Joe Deasy,
More information1. Study Title. Exercise and Late Mortality in 5-Year Survivors of Childhood Cancer: a Report from the Childhood Cancer Survivor Study.
CCSS Analysis Concept Proposal Exercise, Mortality, & Childhood Cancer 1 1. Study Title. Exercise and Late Mortality in 5-Year Survivors of Childhood Cancer: a Report from the Childhood Cancer Survivor
More informationPotential benefits of intensity-modulated proton therapy in head and neck cancer van de Water, Tara Arpana
University of Groningen Potential benefits of intensity-modulated proton therapy in head and neck cancer van de Water, Tara Arpana IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's
More informationPEDIATRIC ORBITAL TUMORS RADIOTHERAPY PLANNING
PEDIATRIC ORBITAL TUMORS RADIOTHERAPY PLANNING ANATOMY ANATOMY CONT ANATOMY CONT. ANATOMY CONT. EYE OF A CHILD Normal tissue tolerance doses (in conventional #) TD 5/5 TD 50/5 Endpoint Gy Gy Optic nerve
More informationExploring the potential for clinical introduction of hippocampal-sparing IMPT of pediatric medulloblastoma - Past present and future
Exploring the potential for clinical introduction of hippocampal-sparing IMPT of pediatric medulloblastoma - Past present and future Daniel Gasic Disclosure Nothing to disclose Introduction Background
More information-Proton Beam Therapy in Paediatric Radiation Oncology -
-Proton Beam Therapy in Paediatric Radiation Oncology - Beate Timmermann, M.D. West German Proton Therapy Centre Essen Germany Preview Survival Toxicity Why protons? (theoretically) Experiences so far
More informationa) Study Title: The impact of chronic disease on health care utilization in the CCSS cohort
Analysis Concept Proposal a) Study Title: The impact of chronic disease on health care utilization in the CCSS cohort b) Working Group Investigators This proposed project will be developed through the
More informationState of the Art Radiotherapy for Pediatric Tumors. Suzanne L. Wolden, MD Memorial Sloan-Kettering Cancer Center
State of the Art Radiotherapy for Pediatric Tumors Suzanne L. Wolden, MD Memorial Sloan-Kettering Cancer Center Introduction Progress and success in pediatric oncology Examples of low-tech and high-tech
More informationEvaluation of Whole-Field and Split-Field Intensity Modulation Radiation Therapy (IMRT) Techniques in Head and Neck Cancer
1 Charles Poole April Case Study April 30, 2012 Evaluation of Whole-Field and Split-Field Intensity Modulation Radiation Therapy (IMRT) Techniques in Head and Neck Cancer Abstract: Introduction: This study
More informationBreast Cancer in Childhood Cancer Survivors: The Impact of Screening on Morbidity
Breast Cancer in Childhood Cancer Survivors: The Impact of Screening on Morbidity WORKING GROUP: This report will be written within the Cancer Control Working Group with oversight from the Second Malignant
More informationNCCN GUIDELINES ON PROTON THERAPY (AS OF 4/23/18) BONE (Version , 03/28/18)
BONE (Version 2.2018, 03/28/18) NCCN GUIDELINES ON PROTON THERAPY (AS OF 4/23/18) Radiation Therapy Specialized techniques such as intensity-modulated RT (IMRT); particle beam RT with protons, carbon ions,
More informationChildhood Cancer Survivor Study Study Proposal: Male Health Questionnaire (MHQ) and CED February 2015
Childhood Cancer Survivor Study Study Proposal: Male Health Questionnaire (MHQ) and CED February 2015 1. STUDY TITLE: Cyclophosphamide Equivalent Dosing and Male Health Late Effects Infertility, Erectile
More informationCCSS Concept Proposal Working Group: Biostatistics and Epidemiology
Draft date: June 26, 2010 CCSS Concept Proposal Working Group: Biostatistics and Epidemiology Title: Conditional Survival in Pediatric Malignancies: A Comparison of CCSS and SEER Data Proposed Investigators:
More informationEvidence tables from the systematic literature search for premature ovarian insufficiency surveillance in female CAYA cancer survivors.
Evidence tables from the systematic literature search for premature ovarian insufficiency surveillance in female CAYA cancer survivors. Who needs surveillance? Chiarelli et al. Early menopause and Infertility
More informationCHILDHOOD CANCER SURVIVOR STUDY ANALYSIS CONCEPT PROPOSAL
CHILDHOOD CANCER SURVIVOR STUDY ANALYSIS CONCEPT PROPOSAL 1. Study title: Subsequent neoplasms among survivors of childhood cancer not previously treated with radiation 2. Working group and investigators:
More informationChapter 7 General conclusions and suggestions for future work
Chapter 7 General conclusions and suggestions for future work Radiation therapy (RT) is one of the principle treatment modalities for the management of cancer. In recent decades, advances in the radiation
More informationUpdated Analysis of Non-Surgical Premature Menopause in the Childhood Cancer Survivor Study
Analysis Concept Proposal 1. Study Title Updated Analysis of Non-Surgical Premature Menopause in the Childhood Cancer Survivor Study 2. Working Group and Investigators CCSS Working Group: Chronic Disease
More informationRadiotherapy Outcomes
in partnership with Outcomes Models with Machine Learning Sarah Gulliford PhD Division of Radiotherapy & Imaging sarahg@icr.ac.uk AAPM 31 st July 2017 Making the discoveries that defeat cancer Radiotherapy
More informationChapter 2. Level II lymph nodes and radiation-induced xerostomia
Chapter 2 Level II lymph nodes and radiation-induced xerostomia This chapter has been published as: E. Astreinidou, H. Dehnad, C.H. Terhaard, and C.P Raaijmakers. 2004. Level II lymph nodes and radiation-induced
More informationAdvances in Radiation Therapy
Advances in Radiation Therapy 2017 Recent Advances in Oncology Michelle Alonso-Basanta, MD PhD Helene Blum Assistant Professor Associate Chief of Clinical Operations Director of Quality Assurance Chief,
More informationQuality of End-of-Life Care in Patients with Hematologic Malignancies: A Retrospective Cohort Study
Quality of End-of-Life Care in Patients with Hematologic Malignancies: A Retrospective Cohort Study David Hui, Neha Didwaniya, Marieberta Vidal, Seong Hoon Shin, Gary Chisholm, Joyce Roquemore, Eduardo
More informationComparison of IMRT and VMAT Plan for Advanced Stage Non-Small Cell Lung Cancer Treatment
Research Article imedpub Journals www.imedpub.com Archives in Cancer Research DOI: 10.21767/2254-6081.100185 Comparison of IMRT and VMAT Plan for Advanced Stage Non-Small Cell Lung Cancer Treatment Abstract
More informationA Dosimetric Comparison of Whole-Lung Treatment Techniques. in the Pediatric Population
A Dosimetric Comparison of Whole-Lung Treatment Techniques in the Pediatric Population Corresponding Author: Christina L. Bosarge, B.S., R.T. (R) (T) Indiana University School of Medicine Department of
More informationPotential benefits of intensity-modulated proton therapy in head and neck cancer van de Water, Tara Arpana
University of Groningen Potential benefits of intensity-modulated proton therapy in head and neck cancer van de Water, Tara Arpana IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's
More informationTitle: Incidence of chronic disease among childhood cancer survivors by treatment era and temporal trends in treatment exposure
Childhood Cancer Survivor Study Analysis Concept Proposal Title: Incidence of chronic disease among childhood cancer survivors by treatment era and temporal trends in treatment exposure Working Group &
More informationIntensity Modulated Radiation Therapy (IMRT)
Intensity Modulated Radiation Therapy (IMRT) Policy Number: Original Effective Date: MM.05.006 03/09/2004 Line(s) of Business: Current Effective Date: HMO; PPO 06/24/2011 Section: Radiology Place(s) of
More informationCancer Prevention & Control in Adolescent & Young Adult Survivors
+ Cancer Prevention & Control in Adolescent & Young Adult Survivors NCPF Workshop July 15-16, 2013 Patricia A. Ganz, MD UCLA Schools of Medicine & Public Health Jonsson Comprehensive Cancer Center + Overview
More informationRadiation Technology, Hyogo Ion Beam Medical Center, Tatsuno, Hyogo, JAPAN
Analysis of Visual Loss Due to Radiation- Induced Optic Neuropathy After Particle Therapy for Head and Neck and Skull Base Tumors Adjacent to Optic Nerves Y. Demizu 1, M. Murakami 1, D. Miyawaki 1, Y.
More informationClinical Protontherapy Head and Neck cancer
Clinical Protontherapy Head and Neck cancer Coen Rasch Department of Radiation Oncology Academic Medical Center Amsterdam No disclosures 1 Introduction Proton vsphotonin the literature Model basedindicationprotocol
More informationDosimetric Comparison of Intensity-Modulated Radiotherapy versus 3D Conformal Radiotherapy in Patients with Head and Neck Cancer
Dosimetric Comparison of Intensity-Modulated Radiotherapy versus 3D Conformal Radiotherapy in Patients with Head and Neck Cancer 1- Doaa M. AL Zayat. Ph.D of medical physics, Ayadi-Al Mostakbl Oncology
More information3. BACKGROUND AND RATIONALE
CHILDHOOD CANCER SURVIVOR STUDY Revised Analysis Concept Proposal 10-17 October 12, 2011 1. STUDY TITLE: Growth Hormone Exposure as a risk factor for the development of Subsequent Central Nervous System
More informationIntroduction: Methods: Results: Conclusions: PATIENTS AND METHODS Key Words: 1770
Original Article Utilization of Hyperfractionated Radiation in Small-Cell Lung Cancer and Its Impact on Survival David Schreiber, MD,* Andrew T. Wong, MD,* David Schwartz, MD,* and Justin Rineer, MD Introduction:
More informationThe Effect of Transition Clinics on Knowledge of Diagnosis and Perception of Risk in Young Adult Survivors of Childhood Cancer
The Effect of Transition Clinics on Knowledge of Diagnosis and Perception of Risk in Young Adult Survivors of Childhood Cancer Rohit G. Ganju, Emory University Ronica H. Nanda, Emory University Natia Esiashvili,
More informationAMORE (Ablative surgery, MOulage technique brachytherapy and REconstruction) for childhood head and neck rhabdomyosarcoma Buwalda, J.
UvA-DARE (Digital Academic Repository) AMORE (Ablative surgery, MOulage technique brachytherapy and REconstruction) for childhood head and neck rhabdomyosarcoma Buwalda, J. Link to publication Citation
More informationChildhood Cancer Survivor Study Analysis Concept Proposal
Childhood Cancer Survivor Study Analysis Concept Proposal Title: Neurologic and Neurosensory Adverse Sequelae in Long-term Survivors of Childhood Brain Tumors: An Update and Expanded Risk Factor Analysis
More informationIntroduction ORIGINAL RESEARCH
Cancer Medicine ORIGINAL RESEARCH Open Access The effect of radiation therapy in the treatment of adult soft tissue sarcomas of the extremities: a long- term community- based cancer center experience Jeffrey
More informationChildhood Cancer Survivor Study Analysis Concept Proposal
Childhood Cancer Survivor Study Analysis Concept Proposal Title: Long-Term Outcomes of Childhood Central Nervous System Tumor Survivors: A Report from the Childhood Cancer Survivor Study Working Group
More informationChildhood Cancer Survivor Study Study Proposal: Male Health Questionnaire (MHQ) November 6, 2012
Childhood Cancer Survivor Study Study Proposal: Male Health Questionnaire (MHQ) November 6, 2012 1. STUDY TITLE: Perceptions of risk for Male Health Problems in childhood and adolescent cancer survivors:
More informationOptimising Radiotherapy Using NTCP Models: 17 Years in Ann Arbor
Individualizing Optimizing Optimising Radiotherapy Using NTCP Models: 17 Years in Ann Arbor Randall K. Ten Haken, Ph.D. University of Michigan Department of Radiation Oncology Ann Arbor, MI Introduction
More informationClinical Quality Assurance for Particle Therapy Plus ça même Plus
Clinical Quality Assurance for Particle Therapy Plus ça même Plus Thomas F. DeLaney, MD Medical Director Francis H. Burr Proton Center Massachusetts General Hospital Boston MA Quality Assurance Designed
More information14. Background. Sarcoma. Resectable extremity soft tissue sarcomas
96 14. Sarcoma Background Radiotherapy is widely used as an adjunct to surgery in the management of soft tissue sarcomas as the risk of failure in the surgical bed can be high. For bone sarcomas, radiotherapy
More informationPTCOG 46. Educational Workshop Session IV. Head & Neck CLINICAL. J. Mizoe (NIRS, Japan)
PTCOG 46 Educational Workshop Session IV CLINICAL Head & Neck J. Mizoe (NIRS, Japan) Photon X-Ray γ-ray Fast Neutron Non-Charged Radiation Electron Proton Helium Light Ion Heavy Particle Carbon Neon Argon
More informationAlexandria University Faculty of Medicine. Alexandria Journal of Medicine.
Alexandria Journal of Medicine (2013) 49, 379 384 Alexandria University Faculty of Medicine Alexandria Journal of Medicine www.sciencedirect.com ORIGINAL ARTICLE Three dimensional conformal postoperative
More informationEfficient SIB-IMRT planning of head & neck patients with Pinnacle 3 -DMPO
Investigations and research Efficient SIB-IMRT planning of head & neck patients with Pinnacle 3 -DMPO M. Kunze-Busch P. van Kollenburg Department of Radiation Oncology, Radboud University Nijmegen Medical
More informationDosimetry for Epidemiology Cohorts Who Receive Radiation Therapy
Dosimetry for Epidemiology Cohorts Who Receive Radiation Therapy Wayne Newhauser, PhD Eurados Winter School, Milan, 2016 Introduction About 1 in 2 men and women born today will be diagnosed with some form
More informationPreventive Rehabilitation In Advanced Chemo-radiated H&N Cancer Patients; 2-year results and dose-effect relationships
ASHA, Nov 2012 Preventive Rehabilitation In Advanced Chemo-radiated H&N Cancer Patients; 2-year results and dose-effect relationships Lisette van der Molen PhD SLP 1, Maya A van Rossum PhD, Ludi E Smeele,
More informationIntensity-modulated radiotherapy followed by a brachytherapy boost for oropharyngeal cancer
ORIGINAL ARTICLE Intensity-modulated radiotherapy followed by a brachytherapy boost for oropharyngeal cancer Abrahim Al-Mamgani, MD, PhD, 1 * Peter C. Levendag, MD, PhD, 1 Peter van Rooij, MSc, 2 Cees
More informationUniversity of Groningen. Dental implants in maxillofacial prosthodontics Korfage, Anke
University of Groningen Dental implants in maxillofacial prosthodontics Korfage, Anke DOI: 10.1016/j.bjoms.2014.05.013 10.1016/j.ijom.2013.04.003 10.1002/hed.24053 IMPORTANT NOTE: You are advised to consult
More informationChildhood Cancer Survivor Study (U24 CA55727)
(U24 CA55727) Report of the Epidemiology and Biostatistics Working Group Ann Mertens, PhD CCSS Investigator Meeting Williamsburg, VA June 9-10, 2010 Publications in past two years Dinu et al. Prediction
More informationClinically Proven Metabolically-Guided TomoTherapy SM Treatments Advancing Cancer Care
Clinically Proven Metabolically-Guided TomoTherapy SM Treatments Advancing Cancer Care Institution: San Raffaele Hospital Milan, Italy By Nadia Di Muzio, M.D., Radiotherapy Department (collaborators: Berardi
More informationDosimetric Analysis of 3DCRT or IMRT with Vaginal-cuff Brachytherapy (VCB) for Gynaecological Cancer
Dosimetric Analysis of 3DCRT or IMRT with Vaginal-cuff Brachytherapy (VCB) for Gynaecological Cancer Tan Chek Wee 15 06 2016 National University Cancer Institute, Singapore Clinical Care Education Research
More informationThe dependence of optimal fractionation schemes on the spatial dose distribution
The dependence of optimal fractionation schemes on the spatial dose distribution Jan Unkelbach 1, David Craft 1, Ehsan Salari 1, Jagdish Ramakrishnan 1,2, Thomas Bortfeld 1 1 Department of Radiation Oncology,
More informationUltrasound study of Normal Tissue Response to Radiotherapy Treatment
Ultrasound study of Normal Tissue Response to Radiotherapy Treatment Tian Liu, PhD Department of Radiation Oncology Emory University, Atlanta, GA Prostate Radiotherapy Erectile Dysfunction in Prostate
More informationRadiation and Hodgkin s Disease: A Changing Field. Sravana Chennupati Radiation Oncology PGY-2
Radiation and Hodgkin s Disease: A Changing Field Sravana Chennupati Radiation Oncology PGY-2 History of Present Illness 19 yo previously healthy male college student began having pain in his R shoulder
More informationEARLY HYPERBARIC OXYGEN THERAPY FOR REDUCING RADIOTHERAPY SIDE EFFECTS: EARLY RESULTS OF A RANDOMIZED TRIAL IN OROPHARYNGEAL AND NASOPHARYNGEAL CANCER
doi:10.1016/j.ijrobp.2008.11.056 Int. J. Radiation Oncology Biol. Phys., Vol. 75, No. 3, pp. 711 716, 2009 Copyright Ó 2009 Elsevier Inc. Printed in the USA. All rights reserved 0360-3016/09/$ see front
More informationImproved Survival after Gross Total Resection of Malignant Gliomas in Pediatric Patients from the HIT-GBM Studies
Improved Survival after Gross Total Resection of Malignant Gliomas in Pediatric Patients from the HIT-GBM Studies CHRISTOF M. KRAMM 1, SABINE WAGNER 2, STEFAN VAN GOOL 3, HANSJÖRG SCHMID 4, RONALD STRÄTER
More informationUniversity of Groningen. Local treatment in young breast cancer patients Joppe, Enje Jacoba
University of Groningen Local treatment in young breast cancer patients Joppe, Enje Jacoba IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
More informationRitu Raj Upreti, S. Dayananda, R. L. Bhalawat*, Girish N. Bedre*, D. D. Deshpande
60 Original Article Evaluation of radiograph-based interstitial implant dosimetry on computed tomography images using dose volume indices for head and neck cancer Ritu Raj Upreti, S. Dayananda, R. L. Bhalawat*,
More informationSALIVARY GLAND CARCINOMAS IN CHILDREN AND ADOLESCENTS: A POPULATION-BASED STUDY, WITH COMPARISON TO ADULT CASES
ORIGINAL ARTICLE SALIVARY GLAND CARCINOMAS IN CHILDREN AND ADOLESCENTS: A POPULATION-BASED STUDY, WITH COMPARISON TO ADULT CASES Iyad Sultan, MD, 1 Carlos Rodriguez Galindo, MD, 2 Sereen Al-Sharabati,
More information3/29/12. Overview. Significance
3/29/12 Late Effects from Radiation Therapy Radiation-Related Cardiac Effects Outcome Evidence Rebecca M. Howell PhD, DABR Overview Background and Significance Challenges of studying radiation related
More informationEffective local and systemic therapy is necessary for the cure of Ewing tumor Most chemotherapy regimens are a combination of cyclophosphamide,
Ewing Tumor Perez Ewing tumor is the second most common primary tumor of bone in childhood, and also occurs in soft tissues Ewing tumor is uncommon before 8 years of age and after 25 years of age In the
More informationEasy task difficult life
Carlo Fallai S.C. Radioterapia 2 Fondazione IRCCS Istituto Nazionale Tumori Milano Easy task difficult life T1N0 GLOTTIC CANCER T1N0 Glottic cancer Initial& ultimate local control in historical series
More informationCitation Key for more information see:
Citation Key for more information see: http://open.umich.edu/wiki/citationpolicy Use + Share + Adapt { Content the copyright holder, author, or law permits you to use, share and adapt. } Public Domain
More informationProject: Reduction of risk of long-term complications of radiotherapy for lymphomas.
Project: Reduction of risk of long-term complications of radiotherapy for lymphomas. PI: Lena Specht, Rigshospitalet, University of Copenhagen Other participants: Ivan Vogelius, physicist, Rigshospitalet,
More informationREIRRADIATION WITH INTENSITY-MODULATED RADIOTHERAPY IN RECURRENT HEAD AND NECK CANCER
ORIGINAL ARTICLE REIRRADIATION WITH INTENSITY-MODULATED RADIOTHERAPY IN RECURRENT HEAD AND NECK CANCER Felix Zwicker, MD, 1,2 Falk Roeder, MD, 1,2 Henrik Hauswald, MD, 1 Christian Thieke, MD, PhD, 2 Carmen
More informationProton therapy for head and neck cancer: current applications and future directions
Review Article Proton therapy for head and neck cancer: current applications and future directions Alexander Lin, Samuel Swisher-McClure, Laura Bonner Millar, Maura Kirk, Caitlyn Yeager, Ali Kassaee, Boong-Keng
More informationRadiotherapy in feline and canine head and neck cancer
Bettina Kandel Like surgery radiotherapy is usually a localized type of treatment. Today it is more readily available for the treatment of cancer in companion animals and many clients are well informed
More informationProtocol. Intensity-Modulated Radiation Therapy (IMRT): Cancer of the Head and Neck or Thyroid
Intensity-Modulated Radiation Therapy (IMRT): Cancer of the (80148) Medical Benefit Effective Date: 01/01/14 Next Review Date: 03/15 Preauthorization No Review Dates: 09/09, 09/10, 03/11, 03/12, 09/12,
More informationIntensity Modulated Radiation Therapy (IMRT)
Intensity Modulated Radiation Therapy (IMRT) Policy Number: Original Effective Date: MM.05.006 03/09/2004 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 03/01/2015 Section: Radiology
More informationPotential benefits of intensity-modulated proton therapy in head and neck cancer van de Water, Tara Arpana
University of Groningen Potential benefits of intensity-modulated proton therapy in head and neck cancer van de Water, Tara Arpana IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's
More informationPaolo Bossi Head and Neck Medical Oncology Unit Istituto Nazionale Tumori Milan, Italy
Orphan Symptoms: XEROSTOMIA Paolo Bossi Head and Neck Medical Oncology Unit Istituto Nazionale Tumori Milan, Italy Conflict of Interest Participation in Advisory Boards: Roche, Merck, Mundipharma, Astrazeneca,
More informationChapters from Clinical Oncology
Chapters from Clinical Oncology Lecture notes University of Szeged Faculty of Medicine Department of Oncotherapy 2012. 1 RADIOTHERAPY Technical aspects Dr. Elemér Szil Introduction There are three possibilities
More informationProtons for Head and Neck Cancer. William M Mendenhall, M.D.
Protons for Head and Neck Cancer William M Mendenhall, M.D. Protons for Head and Neck Cancer Potential Advantages: Reduce late complications via more conformal dose distributions Likely to be the major
More informationCHILDHOOD CANCER SURVIVAL STUDY CONCEPT PROPOSAL
Version: March 3, 2006 CHILDHOOD CANCER SURVIVAL STUDY CONCEPT PROPOSAL I- Title: Neurocognitive and Psychosocial Correlates of Adaptive Functioning in Survivors of Childhood Leukemia and Lymphoma. II-
More informationdiagnosis and initial treatment at one of the 27 collaborating CCSS institutions;
Peer-delivered smoking counseling for childhood cancer survivors increases rate of cessation: the Partnership for Health Study Emmons K M, Puleo E, Park E, Gritz E R, Butterfield R M, Weeks J C, Mertens
More informationNon-Hodgkin s Lymphomas Version
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) Non-Hodgkin s Lymphomas Version 2.2015 NCCN.org Continue Principles of Radiation Therapy PRINCIPLES OF RADIATION THERAPY a Treatment with
More informationCHILDHOOD CANCER SURVIVOR STUDY Long-Term Morbidity in Survivors of Childhood Leukemia with Down Syndrome Analysis Concept Proposal
CHILDHOOD CANCER SURVIVOR STUDY Long-Term Morbidity in of Childhood Leukemia with Down Syndrome Analysis Concept Proposal Working Group and Investigators Genetics Working Group & Chronic Disease Working
More informationProton and heavy ion radiotherapy: Effect of LET
Proton and heavy ion radiotherapy: Effect of LET As a low LET particle traverses a DNA molecule, ionizations are far apart and double strand breaks are rare With high LET particles, ionizations are closer
More informationCollection of Recorded Radiotherapy Seminars
IAEA Human Health Campus Collection of Recorded Radiotherapy Seminars http://humanhealth.iaea.org Conservative Treatment of Invasive Bladder Cancer Luis Souhami, MD Professor Department of Radiation Oncology
More informationDoses in organs at risk during head and neck radiotherapy using IMRT and 3D-CRT
328 research article Doses in organs at risk during head and neck radiotherapy using IMRT and 3D-CRT Magdalena Peszynska-Piorun 1, Julian Malicki 2,3,4, Wojciech Golusinski 5,6 1 Medical Physics Department,
More informationCCSS Neurology Committee Report: 6/08
Neurology Committee Report: 6/08 Roger J. Packer, MD Executive Director Neuroscience and Behavioral Medicine Chairman, Neurology Director, Brain Tumor Institute Children s s National Medical Center Washington,
More informationA STUDY OF PLANNING DOSE CONSTRAINTS FOR TREATMENT OF NASOPHARYNGEAL CARCINOMA USING A COMMERCIAL INVERSE TREATMENT PLANNING SYSTEM
doi:10.1016/j.ijrobp.2004.02.040 Int. J. Radiation Oncology Biol. Phys., Vol. 59, No. 3, pp. 886 896, 2004 Copyright 2004 Elsevier Inc. Printed in the USA. All rights reserved 0360-3016/04/$ see front
More informationChildhood Cancer Survivor Study Analysis Concept Proposal November 12, 2010
Childhood Cancer Survivor Study Analysis Concept Proposal vember 12, 2010 1. Title: Radiation dose and benign thyroid conditions in the Childhood Cancer Survivor Study: analysis of radiation dose-response
More informationCONCEPT PROPOSAL. WORKING GROUP: This report will be written within the Chronic Disease Working Group. Proposed investigators include:
CONCEPT PROPOSAL STUDY TITLE: Impact of Radiation Dose and Volume to the Pancreas on Subsequent Risk of Diabetes Mellitus in Long-term Survivors of Childhood Cancer Treated with Abdominal Radiation: A
More informationAdaptive planning in the context of adaptive radiotherapy
in the context of adaptive radiotherapy Danilo Pasini Radiotherapy Department Università Cattolica del Sacro Cuore - Rome Zagreb 6/8 November Knowledge Based Oncology Individualizing Modelling Adaptive
More informationSelective partial salivary glands sparing during intensity-modulated radiation therapy for nasopharyngeal carcinoma*
Oncology and Translational Medicine DOI 10.1007/s10330-017-0219-9 April 2017, Vol. 3, No. 2, P65 P70 ORIGINAL ARTICLE Selective partial salivary glands sparing during intensity-modulated radiation therapy
More informationDepartment of Radiotherapy & Nuclear Medicine, National Cancer Institute, Cairo University, Cairo, Egypt.
Original article Res. Oncol. Vol. 12, No. 1, Jun. 2016:10-14 Dosimetric comparison of 3D conformal conventional radiotherapy versus intensity-modulated radiation therapy both in conventional and high dose
More informationParotid gland radiation dose-xerostomia relationships based on actual delivered dose for nasopharyngeal carcinoma
Received: 6 May 2017 Revised: 4 February 2018 Accepted: 4 March 2018 DOI: 10.1002/acm2.12327 RADIATION ONCOLOGY PHYSICS Parotid gland radiation dose-xerostomia relationships based on actual delivered dose
More informationTitle: Characterization of drinking in childhood cancer survivors compared to general population
Title: Characterization of drinking in childhood cancer survivors compared to general population Working Group and Investigators: Anne Lown, Rob Goldsby, and Dan Dohan Background and Rationale: During
More informationInternational Multispecialty Journal of Health (IMJH) ISSN: [ ] [Vol-3, Issue-9, September- 2017]
Dosimetric evaluation of carcinoma nasopharynx using Volumetric Modulated Arc Therapy (VMAT): An institutional experience from Western India Dr. Upendra Nandwana 1, Dr. Shuchita Pathak 2, Dr. TP Soni 3,
More informationFirst, how does radiation work?
Hello, I am Prajnan Das, Faculty Member in the Department of Radiation Oncology at The University of Texas MD Anderson Cancer Center. We are going to talk today about some of the basic principles regarding
More informationNew Technologies for the Radiotherapy of Prostate Cancer
Prostate Cancer Meyer JL (ed): IMRT, IGRT, SBRT Advances in the Treatment Planning and Delivery of Radiotherapy. Front Radiat Ther Oncol. Basel, Karger, 27, vol. 4, pp 315 337 New Technologies for the
More informationOriginal Article. Chinese Journal of Cancer
Original Article Long-term outcome and late toxicities of simultaneous integrated boost-intensity modulated radiotherapy in pediatric and adolescent nasopharyngeal carcinoma Chang-Juan Tao 1,2*, Xu Liu
More information